An announcement from Haleon PLC Sponsored ADR ( (HLN) ) is now available.
On April 4, 2025, Haleon PLC announced the purchase and cancellation of 835,136 ordinary shares as part of its share buyback program initiated on March 28, 2025. This transaction is part of Haleon’s strategic efforts to optimize its capital structure, potentially enhancing shareholder value and reinforcing its market position in the consumer health sector.
More about Haleon PLC Sponsored ADR
Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with a portfolio that includes Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals, and Supplements. The company is known for its trusted brands such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum.
YTD Price Performance: 10.70%
Average Trading Volume: 10,587,699
Technical Sentiment Signal: Strong Sell
Current Market Cap: $46.7B
See more data about HLN stock on TipRanks’ Stock Analysis page.